# HMS Ophthalmology OPD Phase 7 Verification

**Date:** 15 October 2026  
**Phase:** 7 - Contact lens and paediatric vision assessments  
**Status:** COMPLETE

## Implemented functionality

- Added `CONTACT_LENS` and `PAEDIATRIC_VISION` to the existing Ophthalmology test-result lifecycle: draft, completion, scoped current/history read, append-only amendment, optimistic concurrency, transaction rollback, and audit.
- Contact-lens results retain trial/final stage, configured optical-product version, OD/OS lens power and physical details, schedule, fit, over-refraction, visual acuity, comfort, ocular response, outcome, education, and follow-up recommendation/reference.
- Contact-lens completion enforces eye data, cylinder/axis dependency, fit/response details, education, and required follow-up detail. Existing follow-up references must belong to the same visit and patient; recommendation dates must follow the assessment.
- Paediatric results retain assessment methods, configured cycloplegic medication and timing, OD/OS alignment and red reflex, amblyopia/binocular details, cooperation, separate parent report, birth/development history, and result codes.
- Paediatric age in months and guardian-record presence are derived from the active Patient record. The branch form profile supplies the paediatric maximum age; the client cannot authoritatively set derived context.
- Final contact-lens results and configured review/contraindication outcomes route for doctor review. Paediatric developmental-review/repeat outcomes also route for doctor review. Neither path performs Phase 8 approval.

## Existing functionality reused

- Phase 5-6 versioned test-result model, task lifecycle, form-profile snapshots, manual/correction provenance, permission and station membership checks, branch/department scope, transactions, audit, documents, and unified result read.
- Branch-versioned `OPTICAL_PRODUCT`, `DRUG_OPTION`, and `FORM_PROFILE` configuration resources.
- Active Patient date of birth and guardian metadata; guardian identity is not copied.
- Existing OPD follow-up resource; Phase 7 validates a reference and does not create a duplicate scheduling subsystem.
- Existing Patient consent/document services remain authoritative. No new consent type was invented because the supplied Ophthalmology FSD does not require one.

## Files and modules changed

- `apps/api/src/modules/ophthalmology/ophthalmology.types.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology-test-result.model.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology.schemas.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology-core-test-contract.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology.repository.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology.service.ts`
- `apps/api/src/modules/ophthalmology/ophthalmology.phase7.test.ts`
- `HMS_OPHTHALMOLOGY_BACKEND_API_CONTRACT_V1.md` (version 1.6.0)
- `HMS_OPHTHALMOLOGY_PHASE0_FSD_ALIGNMENT_MATRIX.md`
- `HMS_Ophthalmology_OPD_Developer_A_Backend_Prompts.md`
- `HMS_OPHTHALMOLOGY_PHASE_7_GAP_NOTE.md`
- `HMS_OPHTHALMOLOGY_PHASE_7_VERIFICATION.md`

Shared model, permission seed, router, frontend, and prototype files were not changed for Phase 7.

## Backend safeguards

- Active matching branch form-profile, optical-product, and drug-option versions are validated server-side.
- Task laterality and result eye containers remain backend-authoritative.
- Patient age/guardian context and follow-up patient/visit context are read from authoritative records.
- Cycloplegic administration, examination, and performed timestamps are ordered and validated.
- Draft completion and amendments use expected task/result versions; concurrent completion permits one winner and returns a conflict for stale work.
- Multi-document result/task/audit mutations use MongoDB transactions and roll back when audit persistence fails.
- Existing assignment, permission, branch, department, station, restricted-data, and audit rules remain in force.

## HMS Local patterns reused

HMS Local OPD consultation, patient, consent, prescription, and follow-up patterns were inspected for integration boundaries. No dedicated contact-lens or paediatric Ophthalmology prototype exists. No prototype was modified and no new visual system or mock-backed UI was introduced.

## Automated verification

- Phase 7 focused suite: **10/10 passed**.
- Combined Phase 5-7 result regression: **75/75 passed**.
- Full API suite: **1005/1006 passed** across 103 files. The sole failure is the pre-existing unrelated `test/department-module-visibility.test.ts` assertion because `AuthRepository.getUserAccessContext()` does not return `context.departments`; no Ophthalmology test failed.
- API typecheck: passed.
- API build: passed.
- Web typecheck: passed when run independently. A first concurrent typecheck/build invocation temporarily failed to open generated `apps/web/tsconfig.tsbuildinfo`; the independent rerun passed.
- Web production build: passed.
- Phase 7-owned ESLint run: passed with zero findings.
- Full API lint: unchanged unrelated baseline of 51 errors in Insurance, Patient, and patient-document storage files.
- Full web lint: unchanged unrelated baseline of 6 errors in existing doctor-signature, patient, and authenticated-media UI files.
- `git diff --check`: passed.

## Manual/live verification

Phase 7 is backend-only and adds no React screen, so no new browser workflow exists to exercise. Live-service behavior is covered through transaction-capable MongoDB replica-set integration tests using the production repository/service paths. Persistence is verified by independent reads after draft/completion/amendment; authentication/logout behavior itself is unchanged.

## Remaining dependency for Phase 8

- DEC-06 production contact-lens types, brands, materials, schedules, fit/outcome options, paediatric methods/results, age boundary, and cycloplegic medication values must be supplied as configuration; none were fabricated.
- Device imports still require approved vendor adapters.
- Contact-lens acceptance is not optical-prescription approval. Consolidated doctor review, final IOL/optical-prescription approval, diagnoses, and treatment plans remain Phase 8.
- `doc/HMS_Release2_FSD.docx` remains absent; the approved Ophthalmology FSD and DEC-01 through DEC-12 continue to govern this module.

Phase 8 has not started and requires explicit owner approval.
